General MedicationsORALGeneric
CEFACLOR
CEFACLOR
Standard Dose
EQ 500MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CEFACLOR is listed in Drugs@FDA under application 065350 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFACLOR Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor HIKMA Submission history Latest submission status date: 2015-07-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFACLOR is listed in Drugs@FDA under application 065350 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFACLOR Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor HIKMA Submission history Latest submission status date: 2015-07-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.